Roberts William T. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Mar 31, 2022
Insider Transaction Report
Form 4
Roberts William T.
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-29+2,500→ 2,500 total - Sale
Common Stock
2022-03-29$11.13/sh−1,023$11,386→ 1,477 total - Exercise/Conversion
Restricted Stock Units
2022-03-29−2,500→ 7,500 total→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
- [F3]The restricted stock units vest or have vested as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date.